DrugPatentWatch Database Preview
Taro Pharms Company Profile
What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?
TARO PHARMS has eleven approved drugs.
There are four US patents protecting TARO PHARMS drugs.
There are nineteen patent family members on TARO PHARMS drugs in twelve countries and thirteen supplementary protection certificates in eight countries.
Summary for Taro Pharms
| International Patents: | 19 |
| US Patents: | 4 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 11 |
Drugs and US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms North | PSORCON | diflorasone diacetate | CREAM;TOPICAL | 020205-001 | Nov 20, 1992 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharms | NAFTIFINE HYDROCHLORIDE | naftifine hydrochloride | CREAM;TOPICAL | 206901-001 | Jan 6, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharms | OXICONAZOLE NITRATE | oxiconazole nitrate | CREAM;TOPICAL | 205076-001 | Mar 7, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Sign Up |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharms Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Israel | 187666 | ➤ Sign Up |
| European Patent Office | 1888026 | ➤ Sign Up |
| Japan | 2007217431 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Pharms Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2008000041 | Germany | ➤ Sign Up | PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218 |
| /1998 | Austria | ➤ Sign Up | PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203 |
| 2008 00029 | Denmark | ➤ Sign Up | PRODUCT NAME: ADAPALEN, BENZOYLPEROXID |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
